Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S15a pseudogene 27 (RPS15AP27) is a processed pseudogene located on chromosome 9 (GRCh37: 110,725,984-110,726,326, reverse strand) in the human genome. It is a non-functional genomic sequence that originated from the parental ribosomal protein S15a (RPS15A) gene via retrotransposition and does not produce a protein product. Pseudogenes like RPS15AP27 are widespread in the genome and generally lack biological function, although rare pseudogenes elsewhere are known to be transcribed or functionally active. There is no evidence that RPS15AP27 plays a role in human disease or serves as a therapeutic target. No current data suggest RPS15AP27 has a functional role or relevance to drug interaction, disease, or biomarker utility. It is classified strictly as a pseudogene and not as a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 27 (RPS15AP27).